Navigation Links
Atrium Innovations to Present at Upcoming 28th Annual Canaccord Adams Global Growth Conference
Date:8/5/2008

QUEBEC CITY, Aug. 5 /PRNewswire-FirstCall/ - Atrium Innovations Inc. (TSX: ATB), a recognized leading developer, manufacturer and marketer of science-based and professionally endorsed products for the health and nutrition industries, today announced that its President and Chief Executive Officer, Mr. Pierre Fitzgibbon, will present a company overview at the upcoming 28th Annual Canaccord Adams Global Growth Conference on Tuesday, August 12, 2008 at 11 am (eastern time), in the San Francisco Room of the InterContinental Boston Hotel in Boston, MA.

A live webcast of Mr. Fitzgibbon's presentation will be available on our website at http://www.atrium-innov.com in the Investors section. A replay will also be available for a period of 90 days on the Company's website.

About Atrium

Atrium Innovations Inc. is a recognized leading developer, manufacturer and marketer of science-based and professionally endorsed products for the health and nutrition industries. The Company focuses primarily on growing segments of the health and nutrition markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium markets a broad portfolio of finished products through its highly specialized sales and marketing network in more than 35 countries, primarily in North America and Europe. Atrium has over 575 employees and operates five manufacturing facilities. Additional information about Atrium is available on its Web site at http://www.atrium-innov.com.


'/>"/>
SOURCE Atrium Innovations Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
2. Atrium Medical Receives FDA Approval for its Novel C-QUR Lite(TM) V-Patch and C-QUR Edge(TM) V-Patch
3. Atrium shows a strong financial performance for its first quarter
4. Atrium Innovations to Hold 2008 First Quarter Financial Results Conference Call and Webcast on May 6
5. Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29
6. Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
7. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
8. Atrium Innovations Announces Management Changes
9. Inverness Medical Innovations Announces Second Quarter 2008 Results
10. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
11. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
(Date:1/22/2015)... 2015   Cypher Genomics, Inc., the leading ... SQNM ), the leading molecular diagnostics company, ... noninvasive prenatal tests (NIPT). Through this agreement, Sequenom ... to advance analysis of clinically-relevant fetal sub-chromosomal variants ...
(Date:1/22/2015)... Jan. 22, 2015  Derma Sciences, Inc. (Nasdaq: ... on advanced wound care, announces that AMNIOEXCEL® and ... been added to the Premier, Inc. Regenerative Skin ... for the AMNIOEXCEL® and AMNIOMATRIX® product lines, which ...
(Date:12/24/2014)... DALLAS and NEW YORK , ... a biopharmaceutical company advancing patient care in critical areas, announced ... of common stock, and warrants to purchase up to an ... of $4.00 per share and $.01 per warrant.  The warrants ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... NanoLogix, Inc. (OTC:,NNLX - News) a nano-biotechnology ... company events:, NanoLogix personnel are manning a ... in Sacramento this week, with the company being,represented ... will be,presenting in the Exhibition Hall today, March ...
... With Needle-free Vaccine Technology and ... Bird Flu Clinical Program, Webcast/teleconference ... IRVING, Texas, March 31 Carrington,Laboratories, Inc. (OTC Bulletin Board: CARN) ... million, or ($0.90) per basic and,diluted share, for the year ended ...
... MONMOUTH JUNCTION, N.J., March 31 Transave, ... inhaled,pharmaceuticals for the site-specific treatment of serious ... an aggregate of $35 million pursuant to,its ... Company,s,Board are Richard Kollender from Quaker BioVentures ...
Cached Biology Technology:NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update 2NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update 3Carrington Reports 2007 Financial Results 2Carrington Reports 2007 Financial Results 3Carrington Reports 2007 Financial Results 4Carrington Reports 2007 Financial Results 5Carrington Reports 2007 Financial Results 6Carrington Reports 2007 Financial Results 7Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing 2Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing 3
(Date:1/22/2015)... , Jan. 22, 2015   EyeLock, Inc. , a market ... appointed Steve Gerber to the new role of ... responsible for leading development of mobile platforms and wearable solutions ... success and innovation in the semiconductor industry to his role ...
(Date:12/22/2014)... 2014 Holiday Season may be the brightest ever for ... the long anticipated floodgates for consumer biometrics may finally ... phones, tablets, and wearable mobile devices that incorporate biometrics ... with nearly 4.8 billion biometric devices by 2020.   ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... "Samsung Galaxy S5 - Home Button Synaptics Fingerprint ... http://photos.prnewswire.com/prnh/20130307/600769 Based ... 5S, Samsung introduces for the first time a fingerprint ...
Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... entomologists will meet June 16-19, 2013 at the Best Western ... South Dakota as the Entomological Society of America,s North Central ... will include: , Forests pests, such as the ... Agricultural insect pests such as the western corn rootworm, the ...
... Paris, France: The group of genetic conditions known as ... always fatal, in the case of affected children at an ... gait, and poor co-ordination of hands, speech and eye movements, ... researchers from France and the US have found a new ...
... (June 9, 2013) Researchers at Whitehead Institute have ... the drugs that are used to increase red blood ... including those resulting from trauma, sepsis, malaria, kidney dialysis, ... capable of increasing this protein,s production without causing the ...
Cached Biology News:Interferon-beta aids balance and movement in mice with spinocerebellar ataxia 7 2Interferon-beta aids balance and movement in mice with spinocerebellar ataxia 7 3Scientists identify potential drug target for treatment-resistant anemias 2
... Wash Pack provides optimized blocking and ... Quality Clarifier: Ready-to-use wash solutions have ... APS Coated Slides for Microarrays (Product ... Blocking Buffer: 1L • Microarray Post ...
Mouse monoclonal antibody raised against a full length recombinant YARS. NCBI Entrez Gene ID = YARS...
Mouse monoclonal antibody raised against a partial recombinant NEK2. NCBI Entrez Gene ID = NEK2...
Mouse monoclonal antibody raised against a partial recombinant JRKL. NCBI Entrez Gene ID = JRKL...
Biology Products: